HN1999000140A - Un metodo para la prevencion del inicio del asma. - Google Patents

Un metodo para la prevencion del inicio del asma.

Info

Publication number
HN1999000140A
HN1999000140A HN1999000140A HN1999000140A HN1999000140A HN 1999000140 A HN1999000140 A HN 1999000140A HN 1999000140 A HN1999000140 A HN 1999000140A HN 1999000140 A HN1999000140 A HN 1999000140A HN 1999000140 A HN1999000140 A HN 1999000140A
Authority
HN
Honduras
Prior art keywords
asthma
same
pharmaceutical salt
salt acceptable
prevention
Prior art date
Application number
HN1999000140A
Other languages
English (en)
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26792214&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN1999000140(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of HN1999000140A publication Critical patent/HN1999000140A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN METODO PARA PREVENIR EL INICIO DEL ASMA CON CETIRIZINA, UN ISOMERO OPTICO INDIVIDUAL DE LA MISMA O UNA SAL FARMACEUTICA ACEPTABLE DE LA MISMA O UNA SAL FARMACEUTICA ACEPTABLE DE LA MISMA. LA FRECUENCIA DEL ASMA, LA DERMATITIS ATOPICA Y LA FIEBRE DEL HENO A AUMENTADO EN LAS ULTIMAS TRES DECADAS EN MUCHOS PAISES (ISAAC, LANCET 1998; 351: 1225-32) Y EL PESO ECONOMICO Y RESPECTO A LA SALUD DE DICHAS ENFERMEDADES ES IMPORTANTE.
HN1999000140A 1998-08-18 1999-08-13 Un metodo para la prevencion del inicio del asma. HN1999000140A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9692998P 1998-08-18 1998-08-18
US9745598P 1998-08-21 1998-08-21

Publications (1)

Publication Number Publication Date
HN1999000140A true HN1999000140A (es) 2001-07-31

Family

ID=26792214

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1999000140A HN1999000140A (es) 1998-08-18 1999-08-13 Un metodo para la prevencion del inicio del asma.

Country Status (16)

Country Link
EP (1) EP1109557B1 (es)
JP (1) JP3878416B2 (es)
AR (1) AR020167A1 (es)
AT (1) ATE228366T1 (es)
AU (1) AU749169B2 (es)
CA (1) CA2340920C (es)
DE (1) DE69904206T2 (es)
ES (1) ES2188232T3 (es)
HN (1) HN1999000140A (es)
MA (1) MA26676A1 (es)
MY (1) MY124089A (es)
PA (1) PA8480401A1 (es)
SA (1) SA99200492B1 (es)
TN (1) TNSN99158A1 (es)
TW (1) TW581675B (es)
WO (1) WO2000010544A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221854A1 (en) * 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
WO2005077371A1 (en) * 2004-02-12 2005-08-25 Ucb Farchim Sa Use of levocetirizine for the preparation of a drug
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof

Also Published As

Publication number Publication date
SA99200492B1 (ar) 2006-06-04
DE69904206T2 (de) 2003-07-17
EP1109557B1 (en) 2002-11-27
AU749169B2 (en) 2002-06-20
TNSN99158A1 (ar) 2005-11-10
CA2340920C (en) 2007-10-16
ES2188232T3 (es) 2003-06-16
WO2000010544A2 (en) 2000-03-02
AR020167A1 (es) 2002-04-10
ATE228366T1 (de) 2002-12-15
MY124089A (en) 2006-06-30
TW581675B (en) 2004-04-01
JP2002523362A (ja) 2002-07-30
CA2340920A1 (en) 2000-03-02
EP1109557A2 (en) 2001-06-27
AU5734699A (en) 2000-03-14
MA26676A1 (fr) 2004-12-20
JP3878416B2 (ja) 2007-02-07
PA8480401A1 (es) 2000-09-29
DE69904206D1 (de) 2003-01-09
WO2000010544A3 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
ATE417610T1 (de) Zusammensetzung enthaltend 6-ä3-(1-adamantyl)-4- methoxyphenylü-2-naphthanoesäure zur behandlung dermatologischer erkrankungen
EE05287B1 (et) Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
IS8175A (is) Píperasín afleiður og aðferðir við notkun þeirra
EA200100524A1 (ru) Амиды антраниловой кислоты и их применение в качестве лекарственных средств
BR0110486A (pt) Antranilamidas e sua aplicação como medicamento
BR0307564A (pt) Derivados de nicotinamida úteis como inibidores de pde4
AR048912A1 (es) Inmunoglobulinas anti-nogo
BR0210707A (pt) Formulações de olopatadina para administração tópica
NO20050063L (no) 2-heteroaryl karboksamider
ES2165878T3 (es) Utilizacion del modafinil para el tratamiento de las apneas del sueño y trastornos de ventilacion de origen central.
ATE323479T1 (de) Zusammensetzung für die verhinderung der glattmuskelkrankheiten, die ascorbat, arginin und magnesium enthält
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
UY27658A1 (es) Derivados de nicotinamida y una sal de tiotropio en combinación para el tratamiento de enfermedades
DE3688038T2 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
NO20074318L (no) Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
ES2061727T3 (es) Sustancias fisiologicamente activas, un procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
PA8603001A1 (es) Compuestos utiles para el tratamiento de enfermedades
EA199700380A1 (ru) Бициклические ароматические соединения, фармацевтическая и косметическая композиции на их основе и применение косметической композиции
UY27656A1 (es) Derivados de nicotinamida y una sal de tiotropio en combinación para el tratamiento de enfermedades
AR012193A1 (es) Nuevas combinaciones terapeuticas
BR0307905A (pt) derivados de benzotiofeno e benzofurano úteis no tratamento de distúrbios hiperproliferativos
CY1110644T1 (el) 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις
HN1999000140A (es) Un metodo para la prevencion del inicio del asma.
CR7198A (es) Tableta que contiene cetirizina y pseudoefedrina